Ulrich Dauer
Director/Board Member bei Atriva Therapeutics GmbH
Vermögen: 26 719 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Ulrich Dauer
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
16
| Public Company | Biotechnology | 16 |
Public Company | Biotechnology | 7 | |
Atriva Therapeutics GmbH
Atriva Therapeutics GmbH BiotechnologyHealth Technology Atriva Therapeutics GmbH is a biopharmaceutical company that develops host-targeting antiviral therapies. It focuses on the development of new antiviral therapies against different respiratory viral infections. The company was founded by Rainer Lichtenberger and Henrik Luer Lueßen in April 2015 and is headquartered in Tuebingen, Germany.
4
| Holding Company | Biotechnology | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Ulrich Dauer
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
BAYER AG | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
NOVARTIS AG | Pharmaceuticals: Major | Director/Board Member Public Communications Contact | |
MEDIGENE AG | Biotechnology | Director/Board Member Director/Board Member | |
MORPHOSYS AG | Biotechnology | Director/Board Member Public Communications Contact | |
G2M Cancer Drugs AG
G2M Cancer Drugs AG Miscellaneous Commercial ServicesCommercial Services Part of Valerio Therapeutics SA, G2M Cancer Drugs AG is a German company that researches new anti-cancer therapeutics and develops selected late-stage products. The private company is based in Frankfurt am Main, Germany. G2M Cancer Drugs was acquired by Topotarget A/S on March 01, 2005. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Technische Universität München | College/University | Undergraduate Degree Doctorate Degree | |
vasopharm GmbH
vasopharm GmbH Pharmaceuticals: MajorHealth Technology vasopharm GmbH operates as a pharmaceutical company. It discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases and their consequences. The firm focuses on therapeutics influencing the bioavailability of nitric oxide. The company was founded by Harald Schmidt and Ulrich Walter in July 1998 and is headquartered in Wuerzburg, Germany. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
TopoTarget UK Ltd.
TopoTarget UK Ltd. Drugstore ChainsRetail Trade TopoTarget UK Ltd. engages in the discovery and development of drugs and therapies to treat cancer. It develops anti-cancer drugs for molecular mechanisms associated with the cell cycle, chromatin control and DNA damage. The company was founded in 2002 and is headquartered in Oxford, the United Kingdom. | Drugstore Chains | Director/Board Member Corporate Officer/Principal | |
Friedrich-Alexander University of Erlangen-Nuremberg | College/University | Doctorate Degree | |
Technische Universität Braunschweig | College/University | Corporate Officer/Principal Undergraduate Degree | |
Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Undergraduate Degree | |
AiCuris GmbH & Co. KG
AiCuris GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services AiCuris GmbH & Co. KG provides research and development services for antiviral and antibacterial agents. The firm develops drugs against viruses such as human cytomegalovirus, herpes simplex virus, hepatitis B virus and human immunodeficiency virus. The company was founded in March 2006 and is headquartered in Wuppertal, Germany. | Miscellaneous Commercial Services | Director/Board Member | |
Jossa Arznei GmbH
Jossa Arznei GmbH Pharmaceuticals: MajorHealth Technology Jossa Arznei GmbH engages in the manufacture and distribution of pharmaceutical products. It holds interest health care and medicine support services. The company was founded March 4, 1997 and is headquartered in Munich, Germany. | Pharmaceuticals: Major | Chief Executive Officer | |
Objektgesellschaft München Jahnstraße 41 und Klenzestraße
Objektgesellschaft München Jahnstraße 41 und Klenzestraße Real Estate DevelopmentFinance Part of Münchener Rückversicherungs-Gesellschaft AG, Objektgesellschaft München Jahnstraße 41 und Klenzestraße is a residential property rental and leasing private company based in Munich, Germany. The CEOs of the German company are Helmut Jeggle, Sebastian Breyer, Thomas Maier. The company rents and leases residential properties, buildings, and apartments. | Real Estate Development | Chief Executive Officer | |
Concentro Management AG
Concentro Management AG Investment ManagersFinance Concentro Management AG is a German company that offers services in corporate development and management. The private company is based in Munich, Germany. The company has offices in Munich, Leipzig, and Stuttgart. The company has supported various insolvency administrators in successful asset transfers and sales of companies. The company has also helped in the age-related succession plan of a shareholder of Ropro Produktions GmbH. Additionally, Concentro Management has increased EBIT and transparency in the group through a comprehensive restructuring program. | Investment Managers | Chairman Director/Board Member | |
Julius-Maximilians-Universität Würzburg | College/University | Doctorate Degree Doctorate Degree | |
LSP Services Deutschland GmbH | Investment Managers | Private Equity Investor Private Equity Investor | |
Max Planck Institute of Biochemistry | College/University | Doctorate Degree Doctorate Degree | |
CorTec GmbH
CorTec GmbH Medical SpecialtiesHealth Technology CorTec GmbH develops a neuro-technological platform for brain activity measurement and stimulation. The firm specializes in the designing a platform based on the CorTec Brain Interchange technology, with focus on opening up therapeutic and diagnostic possibilities. Its application areas encompass treatment, rehabilitation, and assistance technique. The firm also engages in research and development partnerships that deal with technology development programs and funding initiatives. The company was founded by Thomas Stieglitz, Wolfgang Meier, Christina Schwartz, Jorn Rickert, Markus Raab, Christian Henle, Martin Schuttler, and Jorg Fischer in September 2010 and is headquartered in Freiburg, Germany. | Medical Specialties | Director/Board Member | |
Pharma Radebeul GmbH
Pharma Radebeul GmbH Finance/Rental/LeasingFinance Part of Jossa Arznei GmbH, Pharma Radebeul GmbH is a private company that specializes in rentals and leases of industrial machinery. The company is based in Radebeul, Germany. Michael Riemenschneider has been the CEO of the German company since 2020. | Finance/Rental/Leasing | Chief Executive Officer | |
Santo Service GmbH
Santo Service GmbH Real Estate DevelopmentFinance Santo Service GmbH offers construction and management services for real estate. It holds interest in advising and financial management services. The company was founded on September 19, 2007 and is headquartered in Munich, Germany. | Real Estate Development | Chief Executive Officer | |
Minaris Regenerative Medicine GmbH
Minaris Regenerative Medicine GmbH BiotechnologyHealth Technology apceth Biopharma GmbH operates as a contract development & manufacturing organization. The firm specializes in cell-based and gene therapy products (Advanced Therapy Medicinal Products, ATMPs). Its GMP services include quality management, quality control, assay development, process development, cell banking & formulation and project management. The company was founded in 2007 and is headquartered in Munich, Germany. | Biotechnology | Chairman Chief Executive Officer | |
Immunic AG
Immunic AG Pharmaceuticals: MajorHealth Technology Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany. | Pharmaceuticals: Major | Chairman Chief Executive Officer Founder | |
Solaris Pharma Corp.
Solaris Pharma Corp. Pharmaceuticals: MajorHealth Technology Solaris Pharma Corp. engages in the development and commercialization of specialty pharmaceutical products. Its topical dosage forms that are developed at its facility include ointments, gels, creams, lotions, solutions, sprays, and foams. The company was founded by Lakshmi Raghavan in 2014 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Director/Board Member | |
Dr. Ernst Strüngmann Foundation gGmbH
Dr. Ernst Strüngmann Foundation gGmbH Miscellaneous Commercial ServicesCommercial Services Dr. Ernst Strüngmann Foundation gGmbH is a biotechnology research and development company based in Munich, Germany. Dr. Ernst Strüngmann Foundation gGmbH engages in research and development on biotechnology. The German company was founded in 2007, and its CEOs are Andreas Strüngmann, Thomas Strüngmann, and Thomas Maier. | Miscellaneous Commercial Services | Chief Executive Officer | |
Envisagenics, Inc.
Envisagenics, Inc. BiotechnologyHealth Technology Envisagenics, Inc. engages in developing of artificial intelligence platform for discovering drugs. The company was founded by Maria Luisa Pineda and Martin Akerman and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
ATB GmbH
ATB GmbH Financial ConglomeratesFinance ATB GmbH is an investment holding German company founded in 2004. The private company is based in Gera, Germany. | Financial Conglomerates | Chief Executive Officer | |
LBG 2 GmbH
LBG 2 GmbH Real Estate DevelopmentFinance LBG 2 GmbH provides residential real estate services. The private company is based in Munich, Germany. The CEOs of the German company are Helmut Jeggle, Thomas Maier. | Real Estate Development | Chief Executive Officer | |
IMMUNIC, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chief Operating Officer | |
Aicuris Anti-Infective Cures AG
Aicuris Anti-Infective Cures AG Miscellaneous Commercial ServicesCommercial Services Part of Santo Holding (Deutschland) GmbH, Aicuris Anti-Infective Cures AG aims to discover, develop, and deliver innovative, anti-viral drugs to immunocompromised patients aiming to prevent severe condition and life-threatening diseases. The private company is based in Wuppertal, Germany. Aicuris has developed a commercial drug as well as pipeline of clinical-stage and pre-clinical anti-viral candidates. Its lead product Prevymis® (letermovir), a first-in-class non-nucleoside cytomegalovirus (CMV) inhibitor, was licensed to MSD and is commercialized for the prevention of human CMV infections in immunocompromised patients who underwent an allogeneic hematopoietic stem cell transplantation or kidney transplantation. Aicuris wholly owned product candidate, Pritelivir, targeting resistant herpes simplex virus (HSV) infections in immunocompromised patients, is in phase 3 clinical development. The German company was founded in 2006 by Helga Rübsamen-Schaeff. Larry G. Edwards has been the CEO of the company since 2023. | Miscellaneous Commercial Services | Chairman | |
IQM Finland Oy
IQM Finland Oy Information Technology ServicesTechnology Services IQM Finland Oy operates as a quantum computing company. It engages in building hardware for quantum computers that focuses on superconducting technology. The company was founded by Juha Johannes Vartiainen, Kuan Yen Tan, Jan Goetz, and Mikko Pentti Matias M?tt?nen and is headquartered in Espoo, Finland. | Information Technology Services | Director/Board Member | |
SWB Holding GmbH (Bayern)
SWB Holding GmbH (Bayern) Financial ConglomeratesFinance SWB Holding GmbH is a German Munich-based company that was founded in 2013. The private company provides investment services. Thomas Peter Maier has been the CEO of the company since 2018. | Financial Conglomerates | Chief Executive Officer | |
APREA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
A&T Grundstück 1 GmbH
A&T Grundstück 1 GmbH Real Estate DevelopmentFinance A & T Grundstück 1 GmbH is a private company based in Munich, Germany. The CEOs of the German company are Thomas Maier, Sebastian Breyer, Helmut Jeggle. The company engages in buying and selling of commercial premises & non-residential buildings. | Real Estate Development | Chief Executive Officer | |
A&T Grundstück 2 GmbH
A&T Grundstück 2 GmbH Real Estate DevelopmentFinance A & T Grundstück 2 GmbH is a private company based in Munich, Germany. The CEOs of the German company are Sebastian Breyer, Helmut Jeggle, Thomas Peter Maier. The company buys and sells land, buildings, and apartments. | Real Estate Development | Chief Executive Officer | |
Palais Berlin 1 GmbH
Palais Berlin 1 GmbH Real Estate DevelopmentFinance Palais Berlin 1 GmbH is a German company that specializes in the buying and selling of land, buildings, and flats. The private company is based in Munich, Germany. The CEOs of the company are Thomas Maier, Helmut Jeggle, Sebastian Breyer. | Real Estate Development | Chief Executive Officer | |
Kira Biotech Pty Ltd.
Kira Biotech Pty Ltd. BiotechnologyHealth Technology Kira Biotech Pty Ltd. operates as biotechnology company which develops novel immunomodulatory compounds for the treatment of immune system disorders. The company was founded by Georgina Clark is headquartered in Brisbane, Australia. | Biotechnology | Chairman | |
ATHOS KG
ATHOS KG Financial ConglomeratesFinance ATHOS KG is an investment holding German company founded in 2019. The private company is based in Holzkirchen, Germany. | Financial Conglomerates | Chief Executive Officer | |
TONIES SE | Recreational Products | Director/Board Member | |
Atrin Pharmaceuticals, Inc.
Atrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 2012, Atrin Pharmaceuticals, Inc. is a DNA Damage Response development company that focuses on a pipeline of products resulting from a series of novel conformationally restricted macrocyclic molecules. Part of Aprea Therapeutics, Inc., the private company is based in Doylestown, PA. Atrin Pharmaceuticals was acquired by Aprea Therapeutics, Inc. on May 16, 2022 for $1.33 million. The company's products have the highest known potency for inhibiting ATR and exhibit ATR selectivity with potential broad therapeutic profile. | Pharmaceuticals: Major | Director/Board Member | |
New Biohaven Pharmaceuticals, Inc. | Director/Board Member | ||
Verinos Pharmaceuticals GmbH | Director/Board Member Director/Board Member | ||
Vectura GmbH
Vectura GmbH Medical SpecialtiesHealth Technology Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany. | Medical Specialties | Director/Board Member Corporate Officer/Principal | |
Objektgesellschaft Berlin Passauer Straße 5-7 mbH
Objektgesellschaft Berlin Passauer Straße 5-7 mbH Real Estate DevelopmentFinance Objektgesellschaft Berlin Passauer Straße 5-7 mbH is a private company based in Munich, Germany. Part of Münchener Rückversicherungs-Gesellschaft AG, Objektgesellschaft Berlin Passauer Straße 5-7 mbH rents, leases, and owns land, buildings, and apartments. The German company was founded in 1997 and the CEOs are Helmut Jeggle and Thomas Peter Maier. | Real Estate Development | Chief Executive Officer |
Statistik
International
Deutschland | 35 |
Vereinigte Staaten | 9 |
Vereinigtes Königreich | 3 |
Schweiz | 2 |
Finnland | 2 |
Sektoral
Health Technology | 21 |
Finance | 15 |
Consumer Services | 7 |
Commercial Services | 5 |
Retail Trade | 2 |
Operativ
Director/Board Member | 120 |
Chief Executive Officer | 62 |
Corporate Officer/Principal | 49 |
Chairman | 29 |
Independent Dir/Board Member | 18 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Helmut Jeggle | 47 |
Jörg Neermann | 34 |
Thomas Werner | 25 |
Manfred Rüdiger | 22 |
Günter Frankenne | 19 |
Clemens M. Doppler | 17 |
Irina Antonijevic | 17 |
Dinnies Johannes von der Osten | 16 |
Klaus Kühn | 15 |
Enno Spillner | 13 |
Daniel Vitt | 12 |
Michael Grissinger | 12 |
Piet Wigerinck | 10 |
Christian Pangratz | 9 |
Brian D. Morgan | 6 |
- Börse
- Insiders
- Ulrich Dauer
- Unternehmensverbindungen